Back to results
CompletedPhase 2

Glutathione (GSH) In The Treatment of Parkinson's Disease

NCT01177319

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

USF Parkinson's Disease and Movement Disorders Center

Tampa, Florida, United States

View on ClinicalTrials.gov
Glutathione (GSH) In The Treatment of Parkinson's Disease — TrialFind